The Academy has endorsed the practice parameter, Pharmacological Treatment of Migraine Headache in Children and Adolescents, which recently was released by the American Academy of Neurology. The guidelines are published in the April 2005 issue of Pediatrics (page 1107).

“Migraine headache is a major health problem for youth in America,” said Thomas K. Koch, M.D., FAAP, chair of the AAP Section on Neurology, who reviewed the practice parameter. “The parameter is valuable in that it raises awareness of the problem and the importance of effective treatment.”

In addition, “headache burden in the child may influence headache burden in the adult, so aggressive treatment in children may have long-term benefits,” said Dr. Koch.

Although there are many studies of medication efficacy in the treatment of migraines in adults, resulting in a solid base of evidence supporting therapeutic inventions in this age group, the number of studies done in children is...

You do not currently have access to this content.